Informed consent in cancer clinical drug trials in China: a narrative literature review of the past 20 years

Informed consent in cancer clinical drug trials in China: a narrative literature review of the past 20 years

Abstract Background Although the number of cancer clinical drug trials is increasing rapidly in China, issues concerning informed consent in this research context are understudied. By performing a narrative literature review, we aim to describe the current situation and identify the most salient cha...

Full description

Bibliographic Details
Main Authors: Xing Liu, Xiaoran Lu, Wei Zhou, Jessica Hahne, Kaveh Khoshnood, Xiaoting Shi, Yuqiong Zhong, Xiaomin Wang
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Trials
Subjects:
Cancer drugs
Clinical trials
Research ethics
Informed consent
Narrative review
Online Access:https://doi.org/10.1186/s13063-023-07482-y

Similar Items

Similar Items